Curriculum Vitae: Claes Göran Tropé

Professor Claes Tropé, The Norwegian Radium Hospital, Oslo, Norway.

Born in Landskrona, Sweden, February 21st 1943 by Swedish parents.

1962Matriculation examination, Landskrona

1964Cand.philos., University of Lund

1964 – 1971Medical School, University of Lund

1964 – 1967Amanuens, Institution of Anatomy, Lund

1967 – 1970Research assistant, Inst. of Anatomy, Lund

1970 – 1972University lecturer, Inst. of Anatomy, Lund

1972 – 1973Acting Professor, Inst. of Anatomy, Lund

1964 – 1974Teaching of medical students, physiotherapists and nurses in anatomy and tumor biology

1974Authorized Doctor Diploma

1974:Ph.D-Thesis: An in vitro Study of the Effect of Cytostatic Drugs on the DNA Synthesis in Experimental Tumors: Selections of Cell Clones during Growth, Transplantation and Metastases.

1971 – 1974Training in general surgery, University of Lund.

1974 – 1978Training in obstetrics and gynecology, University of Malmö.

1977Asst. Professor (Docent) in Tumor Biology, University of Lund.

1978 – 1981Senior Consultant Associate Professor, Dept. of Gynecologic Oncology, University of Lund

1981 – 1986Head, Dept. of Gynecologic Oncology, University of Lund.

1986 – 2006Professor and Director, Dept. of Gynecologic Oncology, the Norwegian Radium Hospital, Oslo.
1988 →Leader of The National Competence Center of Gynaecological Cancer in Norway

2006 →Professor and Head of the Research and Development Dept of Gynaecological Oncology, Faculty of Medicine, University of Oslo

Teacher in post graduate cancers in:

1978 – 1983head and neck oncology, clinical oncology and radiation

1980 – 2008surgical technique

1977 – 2008chemotherapy

1977 – 1986gynecologic oncology and health control

1977 →oncologic surgery

1979 →tumor biology

Member of various Societies:

The Swedish Medical Society

The Swedish Society of Gynecologic Oncology

The Swedish Society of Obstetrics and Gynecology

The Swedish Society of Medical Oncology

The Swedish Society of Radiation Therapy

The Nordic Society of Obstetrics and Gynecology

The Nordic Society of Radiation Therapy

The European Society of Surgical Oncology

The European Society of Medical Oncology

The European Society of Gynecological Oncology

American Society of Clinical Oncology

The Society of Memorial Gynecologic Oncologists

American Society of Clinical Oncology

The Society of Pelvic Surgeons

The Society of Gynecologic Oncologists
International Gynecological Society

1977The founder of the Swedish Cooperative Ovarian Study Group

1977 – 1986President of the Swedish Society of Gynecologic Oncology

1986The founder of the Nordic Society of Gynecologic Oncology

1986 – 1996President of the Nordic Society of Gynecologic Oncology

1988 – 2002Vice president of the European Society of Gynecological Oncology

1992The founder of the Norwegian Society of Gynecologic Oncology

1992 – 1998Member of the Gynecologic Oncology Cancer Committee of FIGO.

1992 – 2000President of the Norwegian Society of Gynecologic Oncology

2008 – 2009Vice president of The Society of Pelvic Surgeons

At present Leader of the Gynaecological Cancer Treatment Program and Research Program at the Norwegian Radium Hospital.

International Collaboration:

 Department of Pathology, John Hopkins Medical Institutions, Baltimore, MD, USA: Professor Ie-Ming Shih, MD, PhD, Professor Tian-Li Wang, PhD

 Department of Pathology, Norwegian American Hospital, Chicago, IL, USA: Professor Carlos Bedrossian, MD

 NCI Betesda, USA: Professor Elise Kohn

 Department of Pharmacology and Experimental Therapeutics, Faculty of Medicine, Hebrew University, Jerusalem, Israel: Dr. Reuven Reich, PhD, Professor Israel Vlodavsky, Professor Philip Lazarovici

 Department of Pathology, University of British Colombia, Vancouver, Canada: Professor G. Gilk.

 International Society on Gestational and Trophoblastic Disease: Professor Michael Seckl, Hammersmith Hospital, London

 Council member of the International Gynecological Society

Prestigious International Awards:

  1. The Barbara Jordan Visiting Professor Price, Memoral Sloan-Kettering Cancer Center, NY, 1995
  2. The Korean Society of Gynaecologic Oncology and Colposcopy Distinguishing Visiting Professor Price, Seoul, 1997
  3. Society of Pelvic Surgeons’ Certificate of Appreciation, 2001
  4. Distinguished Visiting Professor Price in Obstetrics and Oncology, Chicago Medical School, Loyola University, Rush Medical College, University of Chicago, University of Illinois, Chicago, 2002
  5. The 1st Ernst Wertheim Price, Arbeitsgemeinschaft in Gynekologishe Onkologi (AGO), Innsbruck, 2002
  6. Price of honor. Society of Obstetrics and Gynecology, Norway 2010.

At present Supervisor for the following PhD students:

Mari Bunkholt Elstrand, PhD, currently in program

Hiep Phuc Dong, PhD, currently in program

Thea Hetland, PhD, currently in program

Tutor for 44 doctor theses (PhD) field of tumor biology, gynecologic oncology, general oncology and tumor pathology.

  1. Kristjan Sigurdsson. Malignant epithelial ovarian tumors. A study of prognostic factor and the effects of combined treatments, 1982.
  2. Ernst Simonsen. Malignant tumors of the vulva. A study of the effect of radiotherapy, surgery and chemotherapy in combination or used alone, 1983.
  3. Johan Wennerberg. Tumor cell kinetic studies in heterotransplanted squamous cell carcinoma of the head and neck, 1984.
  4. Helena Willén. Histological aspects on a malignancy grading system for invasive squamous cell carcinoma of the uterine cervix, 1984.
  5. Bengt Lindahl. On flow cytometric DNA patterns and steroid receptor concentrations in endometrial carcinoma and their clinical significance, 1987.
  6. Mårten Fernö. Steroid receptors in human endometrial and breast cancer, and binding sites for tamoxifen and estramustine. A study of analytical procedures and on clinical correlations, 1985.
  7. Peter Wahlberg. Studies on the role of vitamin A in squamous cell carcinoma, 1988.
  8. György Horvath. The role of estradiol in tumor progression of human endometrial carcinomas heterotransplanted into nude mice, 1990.
  9. Vera Maria Abeler. Endometrial carcinoma in Norway. Morphology and prognosis, 1991.
  10. Ignace Vergote. Adjuvant treatment of ovarian carcinoma. A clinical and experimental study, 1992.
  11. Janne Kærn. DNA ploidy in epithelial ovarian malignancies. Prognostic value and therapeutic implications, 1993.
  12. Amin Philip Makar. Prognostic studies in cancer of the ovary and fallopian tube. With emphasis on the CA 125 antigen and c-erbB-2 oncogene. 1993
  13. Cecilie Fahlmann. Regulation of haematolymphoresis: Effects of cytokines and retionids. 1994
  14. Sami Sert. Endometrial karsinomlarda prognostik faktör olarak DNA ploidinin önemi. 1995
  15. Tone Bjørge. Epidemiological studies of uterine cervical cancer; with emphasis on time trends in incidence, survival and mortality, risk factors, prognostic factors and screening. 1996
  16. Ewy Kristiansen. Prevalence and molecular analysis of the human papillomavirus genome in Norwegian women. 1996
  1. Helene Schulerud. Evaluation of morphological and textural nuclear image analysis as a tool in tumor pathology. 1997
  2. Viggo Blomlie. Radiation induced injury of the female pelvis: The value of MR imaging in the detection of injury and its potential impact on patient management.
  3. Frank Karlsen. Analysis of the Human Papillomavirus in Intraepithelial neoplasi and Carcinoma of the Cervix Uteri. 1997
  4. Birgitte Smith-Sørensen. Alterations in the cancer associated genes TP53, CDKN2A, and c-MYC, Development of mutation detection and some functional aspects. 1998
  5. Randi Nordal. Uterine sarcomas in Norway 1956-1992. An epidemiological and clinopathological study. 1998
  6. Gunnar B. Kristensen. Studies on prognostic factors in cervical cancer with special attention to early disease. 1999
  7. Åslaug Helland. Genetic susceptibility and somatic DNA alterations in tumour in relation to prognosis. 2000
  8. Kolbein Sundfør. Studies on the outcome of irradiation-based treatment of cervical cancer with emphasis on tissue oxygenation, local oxygenation, local control and metastasis. 2001
  9. Anne Dørum. Hereditary ovarian cancer in Norway. 2001
  10. Ben Davidson. Ovarian carcinoma and serous effusion – a pathobiological study. 2001
  11. Mark Baekelandt. Studies on prognostic and predictive factors in advanced ovarian cancer with emphasis on clinical drug resistance and its reversal. 2001
  12. Heidi Sire Berner. The cell adhesion molecule CD44 in breast and ovarian carcinomas, a pathobiological study. 2002
  13. Asta Bye. Low fat, low lactose diet used as prophylactic treatment of acute intestinal reactions during pelvic radiotherapy. A prospective randomised study. 2002
  14. Glenny Cecilie Alfsen. Adenocarcinomas and other non-squamous cell carcinomas of the uterine cervix. 2004
  15. Yun Wang. Molecular genetic studies of primary ovarian carcinomas. 2005
  16. Gregg Van de Putte. Prognostic factors in early stage squamous cell cervical carcinoma. 2006
  17. Synne Knopp. Prognostic studies in vulvar squamous cell carcinoma. With emphasis on cell cycle components, human papillomavirus and occult metastases. 2007
  18. Torbjørn Paulsen. Epithelial ovarian cancer. A clinical epidemiological approach on diagnosis and treatment. 2007
  19. Ingvild Vistad. A study of long-term effects after radiotherapy in survivors of locally advanced cervical cancer. 2009
  20. Lilach Kleinberg. Regulators of cell survival and apoptosis in metastatic ovarian carcinoma. 2009
  21. Taran Paulsen Hellebust. Severe late complications after radiotherapy for advanced cervical cancer with special emphasis on brachytherapy. 2009
  22. Astrid Helene Liavaag. Epithelial ovarian cancer survivors. Somatic and metal health, sexuality and quality of life studies. 2009
  23. Trond Melbye Michelsen. Long term somatic and psychosocial morbidity after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer. 2010
  24. Ali Areffard. "Ovarian Cancer; results of an immunoproteomic analysis and correlation to clinical data and immunohistology". 2010
  25. Wanja Kildal. “DNA ploidy as a prognostic marker in selected gynecological malignancies”. 2010
  26. Yuan Yuan. “Diagnostic and prognostic markers of cancers involving the serosal cavities”. 2010
  27. Malin Lando. Genetic alterations in cervical cancer. Consequences for gene regulation and clinical outcome after chemoradiotherapy. 2011
  28. Zhihui Wang. Prognostic significance of 14-3-3s and CDC25s in vulvar squamous cell carcinoma. 2011

Peer reviewed scientific publications: 663

Abstracts from international congresses: 343

Claes Tropé

MD, PhD, Professor and Head of R&D

Department of Gynaecological Oncology

Oslo University Hospital, Radiumhospitalet

P.O. Box 4953 Nydalen, 0424 Oslo, Norway

1